SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Kurth KH, Bouffioux C, Sylvester R, Van Der Meijden AP, Oosterlinck W, Brausi M. Treatment of superficial bladder tumors: achievements and needs. Eur Urol 2000; 37 (Suppl. 3): 19
  • 2
    Brausi M, Colette L, Kurth K et al. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta/T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol 2002; 41: 52331
  • 3
    Kriegmair M, Baumgartner R, Knüchel R et al. Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid. Urology 1994; 44: 83641
  • 4
    Kriegmair M, Baumgartner R, Knüchel R, Stepp H, Hofstädter F, Hofstetter A. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. J Urol 1996; 155: 10510
  • 5
    Koenig F, McGovern FJ, Larne R, Enquist H, Schomacker KT, Deutsch TF. Diagnosis of bladder carcinoma using protoporphyrin IX fluorescence induced by 5-aminolaevulinic acid. BJU Int 1999; 83: 12935
    Direct Link:
  • 6
    Zaak D, Kriegmair M, Stepp H et al. Endoscopic detection of transitional cell carcinoma with 5-aminolevulinic acid: results of 1012 fluorescence endoscopies. Urology 2001; 57: 6904
  • 7
    Jakse G, Algaba F, Malmström P-U, Oosterlinck W. A second-look TUR in T1 transitional carcinoma: Why? Eur Urol 2004; 45: 53946
  • 8
    Köhrmann KU, Woeste M, Kappes J, Rassweiler J, Alken P. Der Wert der transurethralen Nachresektion beim oberflächlichen Harnblasenkarzinom. Akt Urol 1994; 25: 20813
  • 9
    Schips L, Augustin H, Zigeuner RE et al. Is repeated transurethral resection justified in patients with newly diagnosed superficial bladder cancer? Urology 2002; 59: 2203
  • 10
    Grimm MO, Steinhoff C, Simon X, Spiegelhalder P, Ackermann R, Vögeli TA. Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study. J Urol 2003; 170: 4337
  • 11
    Brauers A, Buettner R, Jakse G. Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early? J Urol 2001; 165: 80810
  • 12
    Riedl CR, Daniltchenko D, König F, Simak R, Loening SA, Pflueger H. Fluorescence endoscopy with 5-aminolevulinic acid reduces early recurrence rate in superficial bladder cancer. J Urol 2001; 165: 11213
  • 13
    Kriegmair M, Zaak D, Rothenberger KH et al. Transurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscopy. J Urol 2002; 168: 4758
  • 14
    Filbeck T, Pichlmeier U, Knuechel R, Wieland WF, Roessler W. Clinically relevant improvement of recurrence-free survival with 5-aminolevulinic acid induced fluorescence diagnosis in patients with superficial bladder tumors. J Urol 2002; 168: 6771
  • 15
    Schmidbauer J, Witjes F, Schmeller N et al. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. J Urol 2004; 171: 1358
  • 16
    Sylvester RJ, Oosterlinck W, Van Der Meijden AP. A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. J Urol 2004; 171: 218690